MoonLake Immunotherapeutics (MLTX)
18.49
+4.15
(+28.94%)
USD |
NASDAQ |
Jan 09, 16:00
19.38
+0.89
(+4.81%)
After-Hours: 20:00
MoonLake Immunotherapeutics Market Cap: 1.310B for Jan. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Baxter International, Inc. | 10.83B |
| aTyr Pharma, Inc. | 69.84M |
| BeOne Medicines Ltd. | 37.39B |
| AC Immune SA | 343.05M |
| CRISPR Therapeutics AG | 5.131B |
Market Cap Related Metrics
| PEG Ratio | -0.0352 |
| Price to Book Value | 4.534 |
| Price | 18.49 |
| Earnings Yield | -18.00% |
| PEGY Ratio | -0.0352 |